Search Within

Maria C Pietanza

Formats
  1. Meeting Abstract (67)
  2. Journal Article (50)
  3. Book Section (4)
  4. Correspondence (1)
Groups
  1. Department of Medicine (84)
  2. Solid Tumor Oncology Division (81)
  3. Thoracic Oncology (75)
  4. Department of Pathology and Laboratory Medicine (50)
  5. GSK Faculty (48)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (37)

More Groups

People
  1. Mark Kris (50)
  2. Lee Krug (37)
  3. Charles Rudin (33)
  4. William Travis (33)
  5. Gregory Riely (27)
  6. Natasha Rekhtman (24)

More People

Years
  1. 2019 (2)
  2. 2018 (2)
  3. 2017 (8)
  4. 2016 (16)
  5. 2015 (24)
  6. 2014 (15)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Journal of Thoracic Oncology (26)
  3. Modern Pathology (8)
  4. International Journal of Radiation Oncology, Biology, Physics (6)
  5. Laboratory Investigation (6)
  6. Annals of Oncology (4)

More Publications

Publishers
  1. Elsevier Inc. (39)
  2. American Society of Clinical Oncology (29)
  3. Nature Publishing Group (8)
  4. Nature Research (8)
  5. Oxford University Press (6)
  6. American Association for Cancer Research (5)

More Publishers

Results (122)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Small cell and other neuroendocrine tumors of the lung
    Book Section

    Pietanza, M. C.; Krug, L. M.; Wu, A. J.; Kris, M. G.; Rudin, C. M.; Travis, W. D.
    In DeVita, V. T. Jr; Lawrence, T. S.; Rosenberg, S. A. (Eds.) DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 10th ed (2015)

    Fulltext@MSK | Save
  • The factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer
    Meeting Abstract

    Lok, B. H.; Pietanza, M. C.; Foster, A.; Rudin, C. M.; Perez, C. A.; Ong, L.; Krug, L.; Rimner, A.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • Phase 2 trial of bortezomib in KRAS G12D mutant lung cancers
    Meeting Abstract

    Riely, G. J.; Litvak, A.; Rekhtman, N.; Pietanza, M. C.; Chaft, J. E.; Woo, K.; Paik, P.; Miller, V.; Kris, M. G.; Rodriguez, K.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • NOTCH3 protein expression and outcome in small cell lung cancer (SCLC) and therapeutic targeting with tarextumab (anti-Notch 2/3)
    Meeting Abstract

    Chiang, A.; McLaughlin, J.; Pietanza, M. C.; Spira, A.; Jotte, R.; Gadgeel, S.; Mita, A.; Gluck, L.; Liu, S.; Kapoun, A.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Comprehensive mutation analysis of never-smokers with small cell lung cancer (SCLC)
    Meeting Abstract

    Pietanza, M. C.; Won, H.; Krug, L. M.; Varghese, A. M.; Riely, G. J.; Rekhtman, N.; Wang, L.; Travis, W. D.; Zakowski, M.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • A DLL3-targeted ADC effectively targets pulmonary neuroendocrine tumor-initiating cells to result in sustained tumor regressions
    Meeting Abstract

    Saunders, L. R.; Bankovich, A. J.; Anderson, W. A.; Aujay, M.; Bheddah, S.; Black, K. A.; Desai, R.; Escarpe, P.; Hampl, J.; Park, A.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • A DLL3-targeted ADC, rovalpituzumab tesirine, demonstrates substantial activity in a phase I study in relapsed and refractory SCLC
    Meeting Abstract

    Rudin, C. M.; Pietanza, M. C.; Spigel, D. R.; Bauer, T. M.; Glisson, B.; Robert, F.; Ready, N.; Morgensztern, D.; Kochendoerfer, M. D.; Patel, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Treatment of small-cell lung cancer: American Society of Clinical Oncology endorsement of the American College of Chest Physicians Guideline
    Journal Article

    Rudin, C. M.; Ismaila, N.; Hann, C. L.; Malhotra, N.; Movsas, B.; Norris, K.; Pietanza, M. C.; Ramalingam, S. S.; Turrisi, A. T. 3rd; Giaccone, G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) monotherapy or in combination with ipilimumab (IPI) for treatment of recurrent small cell lung cancer (SCLC)
    Meeting Abstract

    Calvo, E.; Lopez-Martin, J.; Bendell, J.; Eder, J. P.; Taylor, M.; Ott, P. A.; Pietanza, M. C.; Horn, L.; Jäger, D.; De Braud, F.; more...
    Asia-Pacific Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase 1/2 study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032
    Meeting Abstract

    Antonia, S. J.; Bendell, J.; Taylor, M.; Calvo, E.; Jäger, D.; De Braud, F.; Ott, P. A.; Pietanza, M. C.; Horn, L.; Le, D. T.; more...
    Annals of Oncology (2015)

    Fulltext@MSK | Save